<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0001-6002</journal-id>
<journal-title><![CDATA[Acta Médica Costarricense]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. costarric]]></abbrev-journal-title>
<issn>0001-6002</issn>
<publisher>
<publisher-name><![CDATA[Colegio de Médicos y Cirujanos de Costa Rica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0001-60022025000200058</article-id>
<article-id pub-id-type="doi">10.51481/amc.v67i2.1442</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización y evaluación fisioterapéutica de los pacientes con Esclerosis Lateral Amiotrófica en Costa Rica]]></article-title>
<article-title xml:lang="en"><![CDATA[Characterization and physiotherapy evaluation of patients with Amyotrophic Lateral Sclerosis in Costa Rica]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Abadia-Cubillo]]></surname>
<given-names><![CDATA[Karla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Azofeifa-Segura]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Benavides-León]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas-Varela]]></surname>
<given-names><![CDATA[José Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Araya-Alpízar]]></surname>
<given-names><![CDATA[Carlo Magno]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hillaire-Arce]]></surname>
<given-names><![CDATA[Catalina Saint]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Costa Rica, Escuela de Tecnologías de la Salud. San José, Costa Rica. Caja Costarricense de Seguro Social, Centro Nacional de Control del Dolor y Cuidados Paliativos, Departamento de Terapia Física y Rehabilitación ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Caja Costarricense de Seguro Social Centro Nacional de Control del Dolor y Cuidados Paliativos, Departamento de Terapia Física y Rehabilitación. Hospital San Francisco de Asís, Departamento de Terapia Física y Rehabilitación]]></institution>
<addr-line><![CDATA[ Alajuela]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Caja Costarricense de Seguro Social Centro Nacional de Control del Dolor y Cuidados Paliativos Departamento de Terapia Física y Rehabilitación]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Caja Costarricense de Seguro Social Centro Nacional de Control del Dolor y Cuidados Paliativos Departamento de Terapia Física y Rehabilitación]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad de Costa Rica Escuela de Estadística ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Caja Costarricense de Seguro Social Centro Nacional de Control del Dolor y Cuidados Paliativos Departamento de Medicina.]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>67</volume>
<numero>2</numero>
<fpage>58</fpage>
<lpage>65</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S0001-60022025000200058&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S0001-60022025000200058&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S0001-60022025000200058&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  caracterizar el perfil de las personas con esclerosis lateral amiotrófica atendidas en el Centro Nacional de Control del Dolor y Cuidados Paliativos durante el periodo 2020-2022, mediante un análisis de la evaluación clínica y sociodemográfica.  Métodos:  estudio descriptivo, transversal, con revisión retrospectiva de expedientes clínicos de los pacientes atendidos en los programas de consulta externa y domiciliar del servicio de terapia física. Todas las variables analizadas estuvieron relacionadas con la evaluación fisioterapéutica y características demográficas, se estudiaron diferentes pruebas para objetivar el estado físico y funcional del paciente (valoración de la composición corporal por bioimpedancia eléctrica, medición de la fuerza muscular y escala de calificación funcional de la esclerosis lateral amiotrófica revisada); además se valoró la presencia de dolor y el riesgo de caídas, los datos corresponden al momento de iniciar el control en ese centro de salud.  Resultados:  la muestra analizada estuvo compuesta por 200 pacientes, el 61.5% correspondía al género masculino. Las edades de los pacientes, al momento de su valoración, oscilaban entre los 30 y 89 años, aunque la mayoría de los pacientes tenían entre 55 y 59 años. Distribuidos por provincias, 44,5% (89 casos) provenían de San José, seguido de un 15,8% (32 casos) de Alajuela, los demás provenían de las otras provincias. Respecto a las características clínicas de la población estudiada, el fenotipo espinal representó la mayoría de los casos (72%). El promedio de tiempo transcurrido desde el inicio de síntomas hasta el diagnóstico fue de 21 meses. Un 62.8 % de los pacientes no reportaron caídas. En cuanto a la sintomatología dolorosa, un 61.4% indicó dolor en alguna zona anatómica. Con la escala de calificación funcional de la esclerosis lateral amiotrófica revisada, un 37% de los pacientes presentaban afectación en los cuatro dominios (estadio 5), seguidos del 17.4% con afectación en tres dominios (estadio 4), se determinó que un 16.4% correspondía al estadio 3, un 16.9% tenía estadio 2 y solo el 10.9 % tenía estadio 1.  Conclusión:  establecer el perfil de los pacientes es importante y con este estudio se observó que los pacientes atendidos en el servicio de terapia física de este centro nacional especializado presentan estadios avanzados de la enfermedad, con franca alteración en su funcionalidad; además, el dolor es un síntoma común y su localización dependerá del tipo y de los mecanismos causantes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Aim:  To characterize the profile of individuals with amyotrophic lateral sclerosis treated at the National Center for Pain Control and Palliative Care during the 2020-2022 period, through an analysis of clinical and sociodemographic assessments.  Methods:  A descriptive, cross-sectional study was conducted with a retrospective review of the medical records of patients treated in the outpatient and home care programs of the physical therapy service. All variables analyzed were related to the physiotherapy evaluation and demographic characteristics. Various tests were used to assess the patient&#8217;s physical and functional status (body composition assessment using electrical bioimpedance, muscle strength measurement, and the revised Amyotrophic Lateral Sclerosis Functional Rating Scale). The presence of pain and risk of falls were also assessed. Data were obtained from the start of follow-up at the health center.  Results:  The analyzed population consisted of 200 patients, 61.5% of whom were male. Patient ages at the time of assessment ranged from 30 to 89 years, although the majority were between 55 and 59 years old. Distributed by province, 44.5% of users were from San José, followed by 15.8% from Alajuela, 11.4% from Puntarenas, 7.9% from Cartago, 7.4% from Heredia, 6.4% from Guanacaste, and 6.4% from Limón. Regarding the clinical characteristics of the study population, the spinal phenotype represented the majority of cases (72%). The average time elapsed from symptom onset to diagnosis was 21 months. 62.8% of patients reported no falls. Regarding painful symptoms, 61.4% indicated that they experienced pain in some anatomical area. Using the revised amyotrophic lateral sclerosis functional rating scale, 37% of patients had involvement in all four domains (stage 5), followed by 17.4% with involvement in three domains (stage 4), 16.4% were determined to be stage 3, 16.9% were stage 2, and only 10.9% were stage 1.  Conclusion:  Establishing patient profiles is important, and this study found that patients treated in the physical therapy department of this specialized national center present with advanced stages of the disease, with significant impairment in function. Furthermore, pain is a common symptom, and its location depends on the type and underlying mechanisms.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[esclerosis Lateral Amiotrófica]]></kwd>
<kwd lng="es"><![CDATA[Servicios de Fisioterapia]]></kwd>
<kwd lng="es"><![CDATA[Terapia Física]]></kwd>
<kwd lng="es"><![CDATA[Evaluación de Síntomas]]></kwd>
<kwd lng="es"><![CDATA[demografía.]]></kwd>
<kwd lng="en"><![CDATA[amyotrophic Lateral Sclerosis]]></kwd>
<kwd lng="en"><![CDATA[Physical Therapy Services]]></kwd>
<kwd lng="en"><![CDATA[Physical Therapy]]></kwd>
<kwd lng="en"><![CDATA[Symptom Assessment]]></kwd>
<kwd lng="en"><![CDATA[Demography.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghasemi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[RH Jr.]]></surname>
<given-names><![CDATA[Brown]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genética de la esclerosis lateral amiotrófica.]]></article-title>
<source><![CDATA[Cold Spring Harb Perspect Med.]]></source>
<year>2018</year>
<volume>8</volume>
<page-range>a024125</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raymond]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Oskarsson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Horton]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.]]></article-title>
<source><![CDATA[Amyotroph Lateral Scler Frontotemporal Degener.]]></source>
<year>2019</year>
<volume>20</volume>
<page-range>413-20</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bento D da]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[RPD de]]></given-names>
</name>
<name>
<surname><![CDATA[Santos K de]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Minasi]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Ternes]]></surname>
<given-names><![CDATA[YMF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas y epidemiológicas de pacientes com Esclerose Lateral Amiotrófica (ELA) no Brasil Central.]]></article-title>
<source><![CDATA[Medicina (Ribeirão Preto)]]></source>
<year>2022</year>
<volume>55</volume>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiò]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Logroscino]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Hardiman]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Swingler]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Beghi]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors in ALS: A critical review.]]></article-title>
<source><![CDATA[Amyotrophic Lateral Scler]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>310-23</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feldman]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Goutman]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Petri]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mazzini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Savelieff]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amyotrophic lateral sclerosis.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2002</year>
<volume>15</volume>
<page-range>2363-1380</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Longinetti]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of amyotrophic lateral sclerosis: an update of recent literature.]]></article-title>
<source><![CDATA[Curr Opin Neurol.]]></source>
<year>2019</year>
<volume>32</volume>
<page-range>771-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[HR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acelerar el diagnóstico de esclerosis lateral amiotrófica utilizando los criterios Gold Coast y biomarcadores.]]></article-title>
<source><![CDATA[Rev Mex Neuroci.]]></source>
<year>2023</year>
<volume>24</volume>
<page-range>93-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bucheli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bermúdez]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Chuquimarca]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Sambache]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Niato]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis lateral amiotrófica: revisión de evidencia médica para tratamiento.]]></article-title>
<source><![CDATA[Rev. Ecuat. Neurol]]></source>
<year>2013</year>
<volume>22</volume>
<page-range>68-76</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cañadilla Barrios]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa Anoceto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bosque Jiménez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vidaurreta Bueno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cañete Rojas]]></surname>
<given-names><![CDATA[AC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de diseño de un programa de ejercicios físico-terapéuticos para pacientes con esclerosis lateral amiotrófica.]]></article-title>
<source><![CDATA[Rev Podium.]]></source>
<year>2021</year>
<volume>16</volume>
<page-range>772-82</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaitan]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Chaustre]]></surname>
<given-names><![CDATA[DM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rehabilitación basada en ejercicio físico en pacientes con esclerosis lateral amiotrófica.]]></article-title>
<source><![CDATA[Rev Col Med Fis Rehab.]]></source>
<year>2024</year>
<volume>34</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esclerosis lateral amiotrófica. Monografía.]]></article-title>
<source><![CDATA[Rev. Mex. Med. Fís. y Rehab.]]></source>
<year>2003</year>
<volume>15</volume>
<page-range>44-54</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calderón-Sepúlveda]]></surname>
<given-names><![CDATA[RF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escalas de medición de la función motora y la espasticidad en parálisis cerebral.]]></article-title>
<source><![CDATA[Rev Mex Neuroci.]]></source>
<year>2002</year>
<volume>3</volume>
<page-range>285-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leiva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandéz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ostolaza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sivori]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escala revisada de valoración funcional de esclerosis lateral amiotrófica: adaptación transcultural.]]></article-title>
<source><![CDATA[Medicina (B. Aires)]]></source>
<year>2022</year>
<volume>82</volume>
<page-range>525-33</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Santos]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Esteban]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Mora Pardina]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Carmona]]></surname>
<given-names><![CDATA[AC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).]]></article-title>
<source><![CDATA[Amyotroph Lateral Scler.]]></source>
<year>2010</year>
<volume>11</volume>
<page-range>475-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz Corredor]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza Pulido]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Peña Preciado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diseño de un sistema de clasificación para evaluar el grado de discapacidad en pacientes con esclerosis lateral amiotrófica.]]></article-title>
<source><![CDATA[Rev. Colomb. Med. Fis. Rehabil.]]></source>
<year>2011</year>
<volume>21</volume>
<page-range>14-22</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicente-Herrero]]></surname>
<given-names><![CDATA[M.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado-Bueno]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bandrés-Moyá]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Iñiguez-de-la-Torre]]></surname>
<given-names><![CDATA[M.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Capdevilla-García]]></surname>
<given-names><![CDATA[L..]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valoración del dolor. Revisión comparativa de escalas y cuestionarios.]]></article-title>
<source><![CDATA[Rev. Soc. Esp. Dolor.]]></source>
<year>2018</year>
<volume>25</volume>
<page-range>228-36</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinosa-Cuervo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[López-Roldán]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar-Rodríguez]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Conde-Embarcadero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Trejo-León]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[González-Carmona]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gait, balance and independence rehabilitation program in elderly adults in a primary care unit.]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc.]]></source>
<year>2013</year>
<volume>51</volume>
<page-range>562-73</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monzón]]></surname>
<given-names><![CDATA[AM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del test Timed Up And Go en adultos mayores.]]></article-title>
<source><![CDATA[AJRPT]]></source>
<year>2022</year>
<volume>4</volume>
<page-range>55-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abadía-Cubillo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Cascante]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Granados-Acuña]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Cordero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salas-Herrera]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos del riluzol en la evolución clínica y sobrevida de los pacientes con esclerosis lateral amiotrófica en Costa Rica.]]></article-title>
<source><![CDATA[Acta méd. costarric.]]></source>
<year>2005</year>
<volume>57</volume>
<page-range>172-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfaro-Campos]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Ulate-Gómez]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de Esclerosis Lateral Amiotrófica en Costa Rica.]]></article-title>
<source><![CDATA[Revista Terapéutica.]]></source>
<year>2022</year>
<volume>16</volume>
<page-range>79-85</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Qian]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015.]]></article-title>
<source><![CDATA[Brain and Behavior]]></source>
<year>2018</year>
<volume>8</volume>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Epps]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kwan]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz-Abad]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación y tratamiento de la disfagia en la esclerosis lateral amiotrófica: una encuesta sobre la práctica clínica de los patólogos del habla y el lenguaje.]]></article-title>
<source><![CDATA[J Clin Neuromuscul Dis.]]></source>
<year>2020</year>
<volume>21</volume>
<page-range>135-41</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarco-Martín]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Freire]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Andreo-López]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Leyva-Martínez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Soto]]></surname>
<given-names><![CDATA[ML.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malnutrition in Amyotrophic Lateral Sclerosis: Insights from Morphofunctional Assessment and Global Leadership Initiative on Malnutrition Criteria.]]></article-title>
<source><![CDATA[Nutrients]]></source>
<year>2024</year>
<volume>16</volume>
<page-range>2625</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Gómez]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Izaola-Jauregui]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Almansa-Ruiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Sahagún]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Primo-Martín]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pedraza-Hueso]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ultrasonography in Morphofunctional Assessment of Amyotrophic Lateral Sclerosis (ALS).]]></article-title>
<source><![CDATA[Nutrients]]></source>
<year>2024</year>
<volume>16</volume>
<page-range>1021</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shell]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
<name>
<surname><![CDATA[Mar]]></surname>
<given-names><![CDATA[VS]]></given-names>
</name>
<name>
<surname><![CDATA[DaSilva]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation of falls in patients with Amyotrophic Lateral Sclerosis with objective measures of balance, strength, and spasticity.]]></article-title>
<source><![CDATA[NeuroRehabilitation]]></source>
<year>2019</year>
<volume>44</volume>
<page-range>85-93</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatti]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Broggi]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Muzio]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bonetto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alessandro]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desempeño físico en pacientes con esclerosis lateral amiotrófica y su relación con el uso de silla de ruedas y ayuda para la marcha.]]></article-title>
<source><![CDATA[Rehabilitación (Madr)]]></source>
<year>2022</year>
<volume>54</volume>
<page-range>279-83</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiò]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lauria]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pain in amyotrophic lateral sclerosis.]]></article-title>
<source><![CDATA[Lancet Neurol.]]></source>
<year>2017</year>
<volume>16</volume>
<page-range>144-57</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
